Skip to content Skip to footer

Close

Sartar was awarded a U.S. patent

October 16, 2017

Sartar was awarded a U.S. patent for use of anagrelide in cancer therapy.

Tags: innovation Japan patent technology

You May Also Like

Sartar’s therapy method featured in Drug Target Review

Sartar was chosen among the top 30 innovative life science companies in RESI Innovation Challenge

Sartar is hiring a Drug Development Director